Methyl 2-chloro-5H-pyrrolo[3,2-d]pyrimidine-4-carboxylate

Catalog No.: 
ACIMGE787
CAS No.: 
2089277-65-4
Molecular Formula: 
C8H6ClN3O2
Molecular Weight: 
211.61
Methyl 2-chloro-5H-pyrrolo[3,2-d]pyrimidine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$462.00InquiryInquiry
100mg95%$660.00InquiryInquiry
250mg95%$936.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-chloro-5H-pyrrolo[3,2-d]pyrimidine-4-carboxylate
IUPAC Namemethyl 2-chloro-5H-pyrrolo[3,2-d]pyrimidine-4-carboxylate
MDL No.MFCD30724110
Molecular FormulaC8H6ClN3O2
Molecular Weight211.61
SMILESO=C(C1=C(NC=C2)C2=NC(Cl)=N1)OC
InChI KeyZAVZICYQWWROAE-UHFFFAOYSA-N
Synonymmethyl 2-chloro-5H-pyrrolo[3,2-d]pyrimidine-4-carboxylate;5H-Pyrrolo[3,2-d]pyrimidine-4-carboxylic acid, 2-chloro-, methyl ester
CAS No.2089277-65-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACIMGE787 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACCALZ340 route compound structure diagram
    ACCALZ3402090149-31-6In Stock
  4. Then
  5. ACIMGE787 route product structure diagram
    ACIMGE7872089277-65-4
Inquiry

2. ACIMGE787 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIMGE787 route product structure diagram
    ACIMGE7872089277-65-4
Inquiry

3. ACIMGE787 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIMGE787 route product structure diagram
    ACIMGE7872089277-65-4
Inquiry

Comments (0)